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Abstract 
Nitric oxide (NO) is involved in the clearance of several types of bacteria, viruses and para-
sites. Although the roles of NO and CD8
+ T cells in the immune response to malaria have 
been extensively studied, their actual contributions during the blood stages of malaria infec-
tion remain unclear. 
In this work, we corroborate that serum NO levels are not associated with the in vivo 
elimination of the blood stages of Plasmodium chabaudi AS. In addition, we show that CD8
+ T 
cells exhibit increased apoptosis and up regulate the expression of TNF- mRNA on day 4 
post-infection and IFN- and IL-10 mRNA on day 11 post-infection. Interestingly, only the 
levels of IFN- and IL-10 expression are affected when iNOS is inhibited with aminoguanidine 
(AG), suggesting that NO could be involved in the activation of CD8
+ T cells during the blood 
stages of plasmodium infection. 
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1. Introduction 
Malaria  is  still  the  cause  of  nearly  1  million 
deaths every year [1]. Much of the pathology of ma-
laria  is  immune-mediated,  which  implies  that  the 
immune  response  needs  to  be  carefully  regulated. 
Some  potential  regulatory  mechanisms  include  the 
following:  apoptosis,  the  modification  of  cellular 
immune  responses,  the  activities  of  self-regulating 
networks of effector molecules such as NO, IL-10 or 
IFN- [2-4], and CD8+ T cell activation. The optimal 
immune response to malaria infection is characterized 
by  early,  intense,  pro-inflammatory  cyto-
kine-mediated effector mechanisms that kill or clear 
parasite-infected  cells.  This  immediate 
pro-inflammatory  response  is  just  as  rapidly  sup-
pressed by an anti-inflammatory response once para-
site replication has been brought under control. The 
successful  resolution  of  malaria  infection  may  thus 
require  a  regulated  progression  from  one  type  of 
immune response to another [5]. 
NO is a versatile component of the innate im-
mune system, and iNOS-derived NO is involved in 
both the pathogenesis and control of several types of 
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viral,  bacterial  and  parasitic  infections  [6].  The  in-
creased  production  of  endogenous  NO  during 
blood-stage malaria infection has been found to cor-
relate  with  protection  against  Plasmodium falciparum 
[7]. Additionally, NO can be both cytotoxic and cyto-
static to P. falciparum in vitro [8] and can inhibit the 
growth of P. falciparum in vitro [9]. Furthermore, NO 
is able to modulate the immune response via the reg-
ulation of apoptosis and the upregulation of cytokine 
mRNA expression [10-12]. Apoptosis modulates the 
development, maturation, activation and termination 
of  the  lymphocytic  response  [4,  13].  Apoptosis  in-
volves cytokines such as TNF- and IFN-, and small 
molecules, such as NO and reactive oxygen interme-
diates [14], all of which are present at high concentra-
tions in mice during acute infection with P. chabaudi 
AS [15]. 
However, controversy exists as to the role of ni-
tric oxide (NO) in malaria because both protective and 
toxic effects of NO are frequently observed in parallel 
[16, 17].  
CD8+ T cells are involved in both immune and 
regulatory responses and have been proposed to be 
essential  for  protective  immunity  against  the  liver 
stages  of  the  Plasmodium  life  cycle  [18,  19].  CD8+ T 
cells have also been demonstrated to confer protective 
immunity upon adoptive transfer [20]. In contrast, it 
has  been  reported  that  the  presence  or  absence  of 
CD8+  T  cells  does  not  change  the  disease  outcome 
during the blood stages of malaria infection [21, 22]. 
Therefore, the role of CD8+ T cells in the establishment 
of  protective  immunity  against  blood-stage  malaria 
remains a matter of controversy. 
The roles of NO and CD8+ T cells in malaria have 
been extensively studied; however, their actual con-
tributions to the immune response during the blood 
stages of malaria infection have remained controver-
sial. Thus, an investigation of the impact of NO on 
CD8+ T cell apoptosis and on the expression of cyto-
kines by CD8+ T cells is critical for defining the con-
tributions of NO to the immune response during the 
blood stages of malaria infection. 
In this work, we have manipulated NO levels in 
vivo to determine the effect on parasite elimination, 
upregulation  of  immune  response-associated  genes, 
apoptosis  and  cytokine  mRNA  levels  produced  by 
CD4+  T,  CD8+  T  and  NK+  cells  during  blood-stage 
infection with P. chabaudi AS in CBA/Ca mice.  
2. Materials and Methods 
2.1 Mice and parasites  
The CBA/Ca mice were kindly donated by Dr. 
W.  Jarra  (National  Institute  for  Medical  Research, 
London). The mice were bred, fed and maintained in a 
specific pathogen-free environment at the FES Zara-
goza-Universidad  Nacional  Autónoma  de  México 
animal house facilities in accordance with the institu-
tional  and  national  official  guideline 
NOM-062-ZOO-1999 for the use and care of labora-
tory animals. 
Plasmodium chabaudi AS was kindly donated by 
Dr. W. Jarra (National Institute for Medical Research, 
London). 
2.2 Infection and treatment 
For infection, batches  of sex- and age-matched 
(6-8  weeks)  CBA/Ca  mice  were  inoculated  intrave-
nously  (i.v.)  with  5  x  104 P. chabaudi  AS-parasitised 
erythrocytes  (PE).  Each  batch  of  infected  mice  was 
subdivided into three groups of six to eight animals. 
The  first  group  was  treated  with  aminoguanidine 
(AG), a selective inhibitor of iNOS, twice daily (300 
mg/kg dissolved in 100 µL sterile PBS) [23]. The se-
cond group was treated with lipopolysaccharide (LPS, 
1  mg/kg),  and  a  third  group  was  intraperitoneally 
(i.p.) injected with PBS daily for three days. In the first 
two experiments, mice were treated at day 4; in the 
next two experiments, they were treated at day 11; 
and in the last two experiments, mice were treated at 
day 21 post-infection. For additional controls, a par-
allel batch of non-infected mice was divided into three 
groups. One group was treated with AG, another with 
LPS  and  the  third  with  PBS  at  the  same  doses  de-
scribed above. Three hours after the last injection, the 
mice were sacrificed under ether anaesthesia. 
2.3 Blood sampling  
Parasitaemia  was  evaluated  daily  by  examina-
tion  of  Giemsa-stained  thin  blood  smears.  Micro-
scopic  enumeration  of  parasitaemia  was  performed 
under oil using a Zeiss Standard 20 microscope (Cark 
Zeiss  LTD,  Welwyn  Garden  City).  Parasitaemias  of 
0.5%  and  above  were  determined  by  counting  the 
number of parasitised erythrocytes present in a total 
of 200 red blood cells. Lower levels of parasitaemia 
were assessed by counting the number of parasitised 
erythrocytes present in 50 fields. The course of infec-
tion in each group is shown as the geometric mean of 
the percentage of parasitaemia. 
2.4 Nitric oxide quantification  
Nitrate concentration in the serum was evaluat-
ed according to the procedure described by Jacobs et 
al. [15]. Fifteen microlitres of serum from each mouse 
were incubated for 15 min at room temperature with 5 
µL of nitrate reductase (5 U/mL; Boehringer Mann-
heim, Laval, Quebec, Canada) and 15 µL of NADPH Int. J. Biol. Sci. 2011, 7 
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(1.25 mg/mL; Boehringer). After incubation, 100 µL of 
Griess  reagent  (1%  sulphanilamide,  0.1% 
N-(1-naphthyl)ethylenediamine dihydrochloride and 
1%  orthophosphoric  acid  (Sigma  Chemical  Co.  St. 
Louis, MO, USA) and 100 µL of trichloroacetic acid 
(10% aqueous solution) were added, and this mixture 
was incubated for 10 min at room temperature. Next, 
the protein precipitates were removed by centrifuga-
tion at 13,000 rpm for 5 min, and 100 µL of each su-
pernatant  was  transferred  to  a  96-well  flat-bottom 
plate. The nitrate concentration was evaluated in an 
ELISA reader (Stat Fax Plate Translator USA at 540 
nm) using a standard curve made from sodium nitrate 
(Sigma)  diluted  in  pooled  serum  from  uninfected 
control CBA/Ca mice that were treated in the same 
way as the samples. 
2.5 Apoptosis detection 
Externalisation  of  phosphatidylserine  was  de-
tected by annexin-V-FLUOS (Roche Diagnostics, Ba-
sel, Switzerland), as described previously [24]. Briefly, 
1 x 106 spleen cells were suspended in 200 µL reaction 
buffer (10 mM HEPES/NaOH, pH 7.4; 140 mM NaCl 
and 5 mM CaCl2) and 2 µL of annexin-V-FLUOS. Af-
ter incubation for 15 min in the dark at room temper-
ature, the cells were rinsed with reaction buffer and 
suspended in 400 µL of reaction buffer containing 10 
µg/mL of propidium iodide. Fluorescence was ana-
lysed  using  a  FACSCalibur  flow  cytometer  and 
CellQuestTM  software  (Becton  Dickinson,  San  Jose, 
CA, USA). For each sample, 40,000 events were ac-
quired and analysed. The dead cells were excluded by 
gating  for  PI  negative  cells,  and  the  percentage  of 
annexin V positive cells (early apoptosis) was deter-
mined  after  correction  for  non-specific/background 
fluorescence. 
2.6 Cell phenotype characterisation 
The  suspensions  of  1  x  106  spleen  cells  were 
washed in PBS and stained with pre-calibrated dilu-
tions of PE-conjugated anti-mouse -CD3, -CD4, -CD8 
or -B220 monoclonal antibodies (BD Pharmingen, San 
Diego, CA, USA). The cells were incubated for 30 min 
at 4 °C, washed twice with fluorescence activated cell 
sorter (FACS) buffer (0.1% bovine serum albumin and 
0.1% sodium azide/PBS) and suspended in 100 µL of 
FACS buffer. The cells were then stained with annexin 
V, as described in the previous section. 
2.7 Cell phenotype isolation 
The  suspensions  of  1  x  107  spleen  cells  were 
washed  in  PBS,  resuspended  in  100  µL  of  PBS  and 
separated using the commercial EasySepTM StemCell 
Technologies, Vancouver, Canada. Briefly, a different 
tube was used for each phenotype. To each tube con-
taining 1 x 107 total spleen cells 1.5 µL of mouse Fc 
receptor  blocker  was  added,  and  the  samples  were 
mixed and incubated at room temperature for 15 min 
with 0.3 µg/mL of each of the following commercial 
labelling antibodies (BD Pharmingen, San Diego, CA, 
USA): CD19 FITC for B cells, CD4-FITC for CD4+ cells, 
CD8-FITC  for  CD8+  and  NK1.1-FITC  for  NK+  cells. 
The cells were washed with 10-fold excess buffer (PBS 
containing 2% FBS (GIBCO) and 1 mM EDTA) and 
resuspended in 100 µL of the same buffer. Ten micro-
litres  of  EasySepTM  FITC  separation  cocktail  was 
added to each cell suspension, and the samples were 
mixed and incubated at room temperature for 15 min. 
Five microlitres of EasySepTM magnetic nanoparticles 
were added, the samples were mixed and incubated 
at room temperature for 10 min, and the suspensions 
were brought to 2.5 mL with buffer. Next, each tube 
was placed onto a magnet and set for 5 min, and the 
supernatant fraction was poured off. The tubes were 
removed from the magnet, and 2 mL of buffer was 
added.  After  gentle  mixing,  the  tubes  were  placed 
back on the magnet and set aside for 5 min. The su-
pernatant fraction was then poured off, and the cells 
were resuspended in 100 µL of PBS. 
2.8 Real Time-Reverse Transcription-PCR 
(qRT-PCR). 
Groups of infected and non-infected mice were 
treated with AG, LPS or PBS. To evaluate the mRNA 
levels of TNF-, IFN-, IL-10, or β-actin mRNA was 
isolated  from  the  spleen  using  TRIzol  (Invitro-
gen,California, USA). Mice were sacrificed on day 4 
post-infection  to  detect  TNF-  or  on  day  11 
post-infection for IFN- and IL-10. RNA was digested 
with  DNase  I,  according  to  the  manufacturer’s  in-
structions (Invitrogen). RNA was quantified by spec-
trophotometry at 260 nm, and 1.5 µg of RNA was re-
trotranscribed using 1.5 µg of oligo dT (Invitrogen), 
0.5 mM dNTPs (Pharmacia, Uppsala, Sweden), 40 U 
of RNase inhibitor and 200 U of MMLV-RT (Invitro-
gen).  The  measurement  of  mRNA  expression  by 
(qRT)-PCR  was  performed  using  an  ABI  7500  Se-
quence Detection System (Applied Biosystems, Foster 
City, CA). The gene primers were as follows: IFN- 
forward 5’ CGG TGA GAA GAT GTT CCA TGC CAC 
[FAM] G; reverse 5’ TCT CCT TCA GGA CAA TGT 
CAA ACA; TNF- forward 5’ CGG CGT TCT TTG 
AGA TCC ATG C [FAM], reverse 5’ CGT CGT AGC 
AAA CCA CCA AGT G; IL-10 forward 5’CGG TTC 
TGG ACA ACA TAC TGC TAA C [FAM] C, reverse 
5´TGG ATC ATT TCC GAT AAG GCT TG; β-actin 
forward 5’ CGG GTC AGG TAG TCT GTC AGG TCC 
[JOE] G, reverse 5’ CTA TGC TCT CCC TCA CGC Int. J. Biol. Sci. 2011, 7 
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CAT C. Each reaction contained 1X PCR master mix 
buffer (Invitrogen), 10 nM forward and reverse pri-
mers, and 1 µL of cDNA. A melting curve was used to 
verify that there was only one amplicon and no pri-
mer  dimers.  The  thermal  cycler  parameters  were  2 
min at 50°C, 2 min at 95°C, and 45 cycles involving 
denaturation at 95°C for 30 sec, annealing at 60°C for 
45  sec  and  extension  at  72°C  for  45  sec.  Standard 
curves  were  prepared  using  serial  dilutions  of  the 
cDNA. The assays were performed in triplicate. All 
data were normalised to -actin (CT analysis, User 
Bulletin #2, ABI Prism 7700 Sequence Detection Sys-
tem). 
2.9 Statistical Analysis  
Statistical analysis was performed using the Stat 
Graphs  software  (version  5.1).  The  differences  be-
tween groups were tested for statistical significance 
using Student’s t test. A P value of <0.05 was consid-
ered significant. All data are expressed as the mean ± 
S.D. Each experiment was performed in duplicate. 
3. Results 
3.1 Increased levels of apoptosis and nitric 
oxide production and the peak of parasitaemia 
occur on day 11 post-infection in CBA/Ca mice 
infected with P. chabaudi AS.  
One  characteristic  of  the  immune  response  to 
malaria  is  the  early  strong  activation  of  different 
lymphocyte populations. Such a response has to be 
regulated  to  avoid  pathological  consequences  once 
the  parasite  has  been  eliminated.  A  typical  mecha-
nism to regulate the immune response is apoptosis, 
which can be modulated by the NO concentration in 
the serum [25]. To analyse whether parasitaemia lev-
els are associated with both the intensity of apoptosis 
in splenocytes and the  nitric oxide concentration in 
the serum, a batch of CBA/Ca mice was infected with 
P. chabaudi AS, and parasitaemia was measured daily 
(Figure  1A,  left  axis).  On  the  days  indicated,  three 
mice were sacrificed to measure total apoptosis in the 
spleen  (Figure  1B).  In  addition,  nitric  oxide  levels 
were  measured  at  the  indicated  time  points  during 
infection (Figure 1A, right axis). 
P. chabaudi AS infection in CBA/Ca mice is not 
lethal. Parasitaemia began to increase on day 4 fol-
lowing infection (day 0) and reached its peak on day 
11.  Thereafter,  parasitaemia  decreased  until  it  was 
resolved  on  day  21  (Figure  1A).  Interestingly,  the 
maximal  level  of  total  apoptosis  in  the  spleen,  the 
peak of parasitaemia and the highest concentration of 
NO were all detected on day 11 post-infection (Fig-
ures 1A and 1B). 
 
Figure 1. Time course of parasitaemia, NO serum 
levels and apoptosis during P. chabaudi AS infection 
in  CBA/Ca  mice.  CBA/Ca mice were infected with P. 
chabaudi  AS.  Parasitaemia,  apoptosis  versus  serum  NO 
levels were monitored  daily. The graphs present parasi-
taemia compared to NO serum levels (A) and the per-
centage of total spleen cells undergoing apoptosis during 
the infection (B). Each measurement represents the average 
of 6 values obtained from 6 mice. The bars represent the 
standard deviation. * indicates statistical significance com-
pared to control mice treated with PBS. In (B) apoptosis is 
significantly increased from day 4 to 21 post-infection. 
 
3.2 Nitric oxide is not involved in controlling 
parasitaemia in CBA/Ca mice infected with P. 
chabaudi AS.  
Although both RNI (reactive nitrogen interme-
diaries)  and  ROI  (reactive  oxygen  intermediaries) 
have been reported to kill Plasmodium falciparum and 
murine malaria parasites in vitro [26, 27] it has been 
difficult  to  probe  this  function  in  vivo  [28,  29].  To 
evaluate whether serum levels of NO contribute to the 
control  of  parasitaemia  in  vivo,  we  modulated  NO 
production.  Thus,  we  interfered  with  nitric  oxide 
synthesis using AG and we induced NO production 
with LPS in CBA/Ca mice infected with  P chabaudi 
AS.  The  inhibitory  effect  of  AG  is  transitory  [30]; 
hence, the experimental schemes were developed to Int. J. Biol. Sci. 2011, 7 
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maintain  the  inhibition  of  iNOS  for  3  days.  The  21 
days  of  infection  were  divided  into  two  phases.  In 
each phase, we injected the mice i.p. with AG for three 
consecutive days. Figure 2 shows the time course of 
parasitaemia  (white  circles,  grey  squares  and  black 
triangles) and the serum levels of NO (bars). Panels A 
and B represent two independent sets of experiments. 
In panel A, the mice were infected on day zero and 
treated  with  PBS,  AG  or  LPS  on  days  one  to  three 
(black  arrow).  Parasitaemia  and  serum  NO  levels 
were recorded daily from day 0 to 7. In panel B, the 
mice were infected on day zero, and PBS, AG or LPS 
was administered from days 9 to 11 (empty arrow). 
Parasitaemia and serum levels of NO were recorded 
daily from day 0 to 21. The detected NO levels re-
mained  constant  throughout  the  experiment  (ap-
proximately 65 µM). Statistically significant increases 
were only  observed on day 4 (panel A) in the first 
regimen and on days 10, 11 and 12 (panel B) in the 
second. On days 11 and 12, the NO concentrations in 
the control mice reached 116 and 85 µM, respectively, 
and on days 4, 10, 11 and 12, the LPS treatment elic-
ited NO levels of 88, 175, 300 and 180 µM, respective-
ly. In the group treated with AG, the NO levels re-
mained  within  the  basal  range  throughout  the  ex-
periment,  except  on  days  11  and  12  when  they 
reached 73 and 71 µM, respectively. Despite the re-
duction in serum levels of NO in the mice treated with 
AG,  the  time  course  of  parasitaemia  remained  un-
changed in these mice compared to mice treated with 
PBS. Likewise, the dramatic increase in serum levels 
of NO in response to LPS on days 10, 11 and 12 did 
not  alter  the  kinetics  of  parasitaemia  compared  to 
mice treated with PBS. Our attempts to manipulate 
NO levels with AG or LPS did not affect parasitaemia, 
indicating that NO does not play a role in the direct 
elimination of this parasite (Figure 2). 
 
 
Figure 2. Time course of parasitaemia and nitric oxide levels in P. chabaudi AS-infected mice treated with 
aminoguanidine (AG) or LPS. Parasitaemia (left axis) and serum NO concentrations (right axis) were monitored as 
described in the Materials and Methods in two experimental groups (A and B). Each group contained 6 mice. All animals 
were infected with P. chabaudi AS and injected i.p. with PBS, aminoguanidine (AG) or with lipopolysaccharide (LPS) at 
different time points. In group A, after infection with P. chabaudi AS, the mice were injected daily from day 1 to day 3 (black 
arrow in panel A). In group B, the treatment began 8 days after infection, and the mice were injected daily from day 8 to day 
11 (empty arrow in panel B). Each measurement is the average of 6 values obtained from six mice. The bars represent the 
standard deviation. * indicates statistical significance compared to control mice treated with PBS. 
 
 
3.3 Effect of AG on apoptosis of CD4+ T, CD8+ 
T and B220+ splenic cells in P. chabaudi AS in-
fected CBA/Ca mice.  
Apoptosis is an important regulator of the im-
mune response [31-33] and is relevant during malaria 
infection both in murine experimental models and in 
humans  [34-36].  During  malaria  infection,  splenic 
lymphocytes undergo a high degree of activation that 
can promote apoptosis [37]. In addition, it has been 
shown that nitric oxide can prevent or induce apop-
tosis in many cell types [38]. Because maximal serum 
NO levels and the peak of splenic apoptosis occurred 
on the same day, we determined whether these phe-
nomena were related. We wanted to know if different 
populations  of  splenic  lymphocytes  manifested  dif-Int. J. Biol. Sci. 2011, 7 
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ferential  susceptibility  to  NO  levels.  We  analysed 
three different subpopulations of splenic lymphocytes 
during early (day 4), middle (day 11) and late (day 21) 
phases  of  infection  in:  control-,  AG-  or  LPS-treated 
mice. Apoptosis was evaluated in CD4+ T, CD8+ T and 
B220+ cells from the spleen using flow cytometry as 
described in the Materials and Methods section. The 
B220+ cells exhibited the highest levels of apoptosis on 
day 11 post-infection, but treatment with AG or LPS 
did not significantly influence apoptosis (Figure 3 A). 
The  incidence  of  B220+  cell  apoptosis  was  twice  as 
high as that of CD8+ T or CD4+ T cells. The treatment 
with AG or LPS did not alter the levels of CD4+ T cell 
apoptosis, with the exception of a significant decrease 
(-30%)  in  apoptosis  on  day  21 post-infection  in  the 
AG-treated group compared to the PBS-treated mice 
(Figure 3 middle panel). Interestingly, infection with 
P.  chabaudi  AS  significantly  increased  apoptosis  of 
CD8+ T cells. On days 11 and 21 post-infection, we 
observed a similar pattern of the CD8+ T cell popula-
tion as in the CD4+ T cells, in which apoptosis fell by 
25% on day 11 and by 56% on day 21 in the AG treated 
group. Similar to the CD4+ T cells from LPS-treated 
mice, no significant increase in CD8+ T cells apoptosis 
was  observed  on  days  11  or  21  (Figure  3C).  These 
findings suggest that NO levels can modulate apop-
tosis only at specific time points and in specific sub-
sets of splenic lymphocytes. It should be noted that 
the increase in apoptosis of CD8+ splenocytes after P. 
chabaudi infection indicates that these cells were stim-
ulated  during  the  blood  stages  of  malaria  infection 
and the fact that apoptosis is reduced by AG treat-
ment suggests a role for NO in this process. 
 
 
 
Figure 3. Apoptosis in three different splenic lymphocyte populations from P. chabaudi AS infected mice 
treated with AG or LPS. The mice were infected and treated as described in Figure 2. At the indicated days, the mice 
were sacrificed and the cells were isolated from the spleen and stained for lymphocytic markers (B220
+, CD4
+ and CD8
+) 
and for apoptosis before analysis by flow cytometry. The histograms represent the percentage of apoptosis in each cell 
subpopulation. Each bar represents the average number of cells from three independent mice ± standard deviation. * in-
dicates statistical significance compared to control mice treated with PBS on the indicated days. CT: control; AG: amino-
guanidine; LPS: lipopolysaccharide. Each result is representative of at least two different experiments. Int. J. Biol. Sci. 2011, 7 
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Figure 4. qRT-PCR of IFN- and IL-10 in three subpopulations of spleen cells on day 11 of P. chabaudi AS 
infection. Eleven days after the infection, CD4
+, CD8
+ or NK.1 (NK) positive cells were isolated from the total spleen cells 
from control (PBS) or P. chabaudi AS-infected mice (I) treated with or without aminoguanidine (AG). cDNA from each 
population was used to perform qRT-PCR using primers specific for IFN- IL-10 or β-actin. All of the procedures were 
performed as described in the Material and Methods. The results are expressed as the average value ± the standard deviation 
of the mean of the relative signals for each cytokine normalised to β-actin. n = 6, * indicates statistically significant differ-
ences. 
 
3.4 Effect of AG on IFN- expression by CD4+ 
T, CD8+ T and B220+ splenic cells in P. chabaudi 
AS infected CBA/Ca mice.  
The increase in CD8+ T cells apoptosis on days 11 
and  21  post-infection  together  with  the  decrease  in 
apoptosis observed in response to AG suggests that 
NO participates in the regulation of CD8+ cells during 
P. chabaudi AS infection. An additional measurement 
of cell function is the production of cytokines, such as 
IFN-  or  IL-10.  In  particular,  NK  cells  have  been 
shown to be a major source of IFN- in P. chabaudi AS 
malaria  [39,  40].  Therefore,  we  assessed  whether 
changes in NO levels could modulate IFN- expres-
sion. First, we measured IFN- mRNA levels in the 
total spleen on days 4, 11 and 21 post-infection (data 
not  shown).  A  significant  increase  in  the  levels  of 
IFN- was detected on day 11 post-infection. We thus 
isolated CD4+ T, CD8+ T or NK+ cells from the spleens 
of P. chabaudi AS-infected mice treated with AG using 
negative  selection  to  analyse  the  mRNA  levels  of 
IFN- (Figure 4A). Infection with  P. chabaudi AS re-
sulted in a significant upregulation of IFN- mRNA 
levels in CD4+ T and NK cells (I+PBS). Interestingly, 
CD8+ T cells also manifested significantly increased 
levels of IFN- mRNA. Furthermore, when iNOS was 
inhibited by the AG treatment, the expression of the 
IFN-gene in CD4+ T, CD8+ T and NK+ cells fell by 83, 
84  and  92  %,  respectively  (the  differences  are  indi-
cated in brackets). These results suggest that NO is 
required  for  the  upregulation  of  IFN-mRNA  ex-
pression in CD4+ T, CD8+ T and NK+ spleen cells in P. 
chabaudi AS infected CBA/Ca mice. Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
1408 
3.5 Effect of AG on the expression of IL-10 by 
CD4+ T, CD8+ T and NK+ splenic cells in P. 
chabaudi AS-infected CBA/Ca mice.  
IL-10  plays  a  protective  role  against  cerebral 
malaria during Plasmodium berghei (ANKA) infection 
[41], and is well known to suppress the inflammatory 
responses  induced  by  IFN-  [42]  Because  IFN- 
mRNA  expression  was  downregulated  when  NO 
synthesis was inhibited in CD4+, CD8+ and NK+ cells, 
we  further  investigated  whether  there  was  also  an 
effect  on  IL-10  expression  in  these  cell  subpopula-
tions. The mRNA levels of this cytokine were assessed 
on day 11 after P. chabaudi AS infection in mice treated 
with AG (Figure 4 B). An upregulation of IL-10 was 
detected on day 11 post-infection. Treatment with AG 
led to reduced IL-10 mRNA levels in all three sub-
populations analysed, falling 64, 61 and 56 % in CD4+, 
CD8+ and NK+ cells, respectively. The effect of AG on 
IL-10 expression suggests that NO is involved in reg-
ulating  IL-10  mRNA  levels  in  splenic  lymphocytes 
from CBA/Ca mice that have been infected with P. 
chabaudi AS. 
3.6 AG has no effect on the mRNA levels of 
TNF- in CD4+, CD8+ and NK+ splenic cells in 
P. chabaudi AS-infected CBA/Ca mice.  
We  have  previously  observed  an  increase  in 
TNF- mRNA levels in the total spleens of P. chabaudi 
AS-infected CBA/Ca mice on day 4 (data not shown). 
In  addition,  TNF-  is  recognised  as  an  important 
modulator associated with both the development of 
immunity  and  the  pathogenesis  of  severe  malaria 
[43-45]. The levels of IFN- and IL-10 were influenced 
by AG treatment during the mid-phase of infection 
(day 11), when NO levels in the serum reached their 
highest levels. Consequently, we evaluated the effect 
of AG on TNF- mRNA levels during the early phase 
of infection (day 4), when parasitaemia begins to in-
crease and no change in serum NO levels were de-
tected (Figure 5). Infection with P. chabaudi AS signif-
icantly increased the expression of TNF- mRNA in 
all of the cells analysed. However, TNF- expression 
was not significantly affected by AG treatment in any 
of the three cell populations analysed. In support of 
the idea that CD8+ cells are activated during the early 
phase of P. chabaudi AS infection (day 4), we observed 
a  marked  increase  in  TNF-  mRNA  levels  in  CD8+ 
cells. These results were anticipated because the levels 
of NO did not change between the PBS control and 
AG treated groups at day 4 post-infection. This find-
ing suggests that NO is not relevant for the upregula-
tion of TNF- mRNA during the early phase of infec-
tion with P. chabaudi AS. 
 
Figure  5. qRT-PCR  of  TNF-in  three  subpopula-
tions of spleen cells at day 4 of P. chabaudi AS in-
fection. Four days after the infection, CD4
+, CD8
+ or NK
+ 
cells were isolated from total spleen cells as described in the 
Material and Methods section. The control animals were 
injected with PBS and the experimental groups were in-
fected with P. chabaudi AS (I) and treated with or without 
aminoguanidine  (AG).  cDNA  from  each  population  was 
used to perform qPCR using primers specific for TNF- or 
β-actin. All of the procedures were performed as described 
in the Materials and Methods section. The results are ex-
pressed as the average values ± the standard deviation of 
the mean of the relative TNF- signal normalised to β-actin. 
n = 6. 
 
4. Discussion 
The participation of CD8+ T cells and nitric oxide 
in  the  blood  stages  of  malaria  infection  has  been  a 
matter of controversy [46]. In this work, we provide 
evidence that splenic CD8+ cells undergo apoptosis at 
increased frequency and upregulate the expression of 
TNF- mRNA on day 4 and IFN- and IL-10 mRNA 
on day 11 post-infection. Interestingly, the expression 
of IFN- and IL-10 in CD8+ cells appeared to be de-
pendent on nitric oxide levels because inhibition of 
iNOS by AG decreased the mRNA levels of these cy-
tokines. 
The  adaptive  immune  response  to  blood-stage 
malaria parasites is dependent on both cell- and an-
tibody-mediated  immune  mechanisms.  Several  au-
thors  have  shown  that  activated  CD4+  cells  release 
factors, including IFN-, which drive parasite-killing 
mechanisms [47]. Detection of fragmented DNA and 
condensed  chromatin  in  P.  falciparum  suggest  that 
apoptotic and/ or cytotoxic mechanisms are respon-
sible for the killing of blood-stage malaria parasites 
[48]. Both reactive oxygen intermediates and reactive 
nitrogen intermediates, especially NO, have been im-
plicated  as  possible  malaria  parasite-killing  agents 
[49, 50]. Int. J. Biol. Sci. 2011, 7 
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Most ROIs, including hydrogen peroxide (H2O2) 
and superoxide ions (O2-), can function independently 
as cytotoxic agents or mediate the formation of other 
toxic molecules in the presence of NO, including the 
hydroxyl radical OH-, hypochlorous acid (HOCl) and 
peroxynitrite  (ONOO-)  [51].  It  is  interesting  to  note 
that all these molecules are associated with the regu-
lation of apoptosis. 
Although there is no doubt that NO is produced 
during Plasmodium infection, the precise role of NO 
during the blood stages has been questioned [30, 52]. 
We show that three events, an increase in serum nitric 
oxide levels, parasitaemia and apoptosis in the spleen, 
all reached peak levels on day 11 post-infection. In an 
attempt to study whether nitric oxide is involved in 
the regulation of the immune response against  ma-
laria parasites by inducing apoptosis in lymphocytes 
during the peak of parasitaemia, we manipulated NO 
levels in vivo. We interfered with NO synthesis using 
AG,  or  alternatively,  we  increased  NO  levels  with 
LPS. Our findings indicate that variations in NO lev-
els had no effect on the destruction of blood-stage P. 
chabaudi AS parasites in vivo. This result is consistent 
with  previous reports  [52-54]. However, our results 
contrast with the earlier studies of Taylor-Robinson 
[50], who demonstrated that both mortality and the 
levels of parasitaemia were associated with the modi-
fication of nitric oxide levels by the administration of 
L-NAME  in  NIH  mice  that  were  infected  with  P. 
chabaudi AS. One probable explanation for the differ-
ence between our study and that of Taylor-Robinson 
is that the effect of NO on cell death could differ be-
tween  various  strains  of  mice,  considering  that  he 
used the NIH strain whereas we used CBA/Ca mice. 
Because NO and O2- are extremely reactive mol-
ecules, they can form ONOO- under normal physio-
logical conditions  [55,  56], ONOO- can protonate to 
generate  OH
  and  nitrogen  dioxide  radicals  (.NO2), 
which are both more reactive than the peroxynitrite 
precursors  [51].  Unlike  NO,  which  has  antioxidant, 
anti-inflammatory,  and  tissue-protective  properties, 
ONOO- is capable of damaging lipids [57], proteins 
[58],  and  nucleic  acids  [59]  and  facilitating  re-
dox-induced apoptosis [60], Peroxynitrite has a criti-
cal role in the immune defence mechanisms against 
numerous pathogens, including Mycoplasma pulmonis, 
Rhodococcus equi [61, 62], Trypanosoma and Salmonella 
spp, most of which have developed defence mecha-
nisms  to  nullify  the  toxic  effect  of  ONOO-  [63,  64]. 
Although the effect of ONOO- on blood-stage malaria 
parasites  is  not  clear,  it  has  been  suggested  that 
ONOO- may play a role in the pathogenesis of cere-
bral malaria by inducing the apoptosis of endothelial 
cells [65]. 
The immune system is strongly activated during 
malarial infection. Apoptosis is an important physio-
logical process for removing cells, including those that 
are generated in excess that have already completed 
their specific functions or that are harmful to the host 
[33]. When NO is oxidised to reactive nitrogen spe-
cies, it elicits various biological effects, including the 
regulation of apoptosis [66, 67]. Parasite destruction is 
supposed to occur in the spleen, but NO levels are 
usually  measured  in  the  serum.  Therefore,  in  this 
work,  we  determined  whether  variations  in  serum 
NO levels affect cytokine production by splenic lym-
phocytes in malaria-infected mice. Our results suggest 
that while AG prevents an increase in serum NO, it 
has  a  limited  efficacy  in  reducing  apoptosis  in  the 
total  splenic  cell  population.  In  contrast,  the  AG 
treatment had a profound effect on the production of 
IFN- and IL-10 by CD4+ T, CD8+ T and NK+ splenic 
lymphocytes.  This  suggests  that  splenic  NO  levels 
rather than serum NO levels, might be relevant dur-
ing lymphocyte activation in response to blood-stage 
plasmodium infection. Consequently, a more detailed 
analysis  of  splenic  NO  production  may  be  a  better 
parameter to evaluate the role of NO during plasmo-
dium infection. 
In  support  of  our  observations,  a  few  groups 
have recently demonstrated the expansion of splenic 
CD8+ T cells during the blood stages of malaria infec-
tion [68-70]. In addition, using bromodeoxyuridine, it 
has been shown that CD8+ T cells are activated during 
blood-stage malaria infection and that activated CD8+ 
T cells express different markers such as IL-7R, PD-1 
and CD62L [46]. Other authors have suggested that 
CD8+ T cells producing IFN-, perforin and granzyme 
B are involved in protective immunity against murine 
blood-stage infection with Plasmodium yoelii 17XL [70].  
Taken  together,  our  results  indicate  that  NO 
could be involved in the regulation of CD8+ T cells 
during the blood stages of Plasmodium infection. This 
finding extends our understanding of the role of both 
NO and CD8+ T cells in the immune responses against 
Plasmodium. 
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